Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 30 for “"antithrombotic"”.

  1. Antithrombotic agents under flow conditions

    … inhibition by two distinct classes of antithrombotic agents: anti-platelet antibodies and anticoagulants, including unfractionated heparin (UFH), low molecular weight heparin (LMWH) and hirudin. <br></br><br></br>Increasing flow rates increased TG, which was higher in the presence of …

    the-open-u Repository record for Antithrombotic agents under flow conditions (opens in a new tab)

  2. Physicochemical study of solid Cyclodextrin inclusion complexes of the antithrombotic Ajoene

    This study describes the preparation and physicochemical characterization of inclusion complexes formed between selected cyclodextrins (CDs) and ajoene, an antlthrombotlc found in garlic. The E and Z isomers of ajoene (4,5,9,-trithiadodeca-1,6,11-triene-9-oxide) were reacted with α, β, γ-CD …

    cape-town Repository record for Physicochemical study of solid Cyclodextrin inclusion complexes of the antithrombotic Ajoene (opens in a new tab)

  3. Antithrombotic and anti-inflammatory activity of ethyl acetate extract of Protorhus longifolia stem bark

    … Despite great efforts made in the discovery of antithrombotic agents, ischemic events continue to claim more lives. Thus, there is a need to discover and develop new and more effective antithrombotic drugs, preferably from natural sources. The study is aimed at investigating the anti-thrombotic …

    zulu Repository record for Antithrombotic and anti-inflammatory activity of ethyl acetate extract of Protorhus longifolia stem bark (opens in a new tab)

  4. UNDERSTANDING GENERALIZED ALLOSTERY IN THROMBIN

    … a critical drug target for chemotherapeutic and antithrombotic therapy development. Although many experiments have demonstrated that thrombin is a multifunctional allosteric enzyme, the exact mechanism of thrombin's allostery is still unclear and widely debated. This dissertation describes my …

    wfu Repository record for UNDERSTANDING GENERALIZED ALLOSTERY IN THROMBIN (opens in a new tab)

  5. Synthesis of pinane thromboxane A₂ via suzuki-miyaura coupling

    … analog of the unstable thromboxane A₂ [2]. Its antithrombotic activity includes the inhibition of platelet aggregation, artery constriction, and thromboxane synthetase [2] and the contraction of induced stomach muscle [3].</p> <p>This project focuses on the synthesis of pinane thromboxane A₂ via …

    emich Repository record for Synthesis of pinane thromboxane A₂ via suzuki-miyaura coupling (opens in a new tab)

  6. Endovascular Optical Coherence Tomography Imaging in Cerebrovascular Disease

    … and residual thrombus. OCT may guide future antithrombotic treatment for patients with demonstrated residual thrombus. OCT carries great promise in the future of neurointerventional surgery.

    toronto-retro Repository record for Endovascular Optical Coherence Tomography Imaging in Cerebrovascular Disease (opens in a new tab)

  7. Feasibility and Acceptability of a SystemCHANGE™ Intervention to Improve Medication Adherence in Older Adult Stroke Survivors: A Pilot Randomized Controlled Trial

    … 2-month SystemCHANGE™ intervention to enhance antithrombotic medication adherence (MA) in 30 older non-adherent stroke survivors recruited from a Midwestern neurology office using an RCT design with an attention-control group. SystemCHANGE™, grounded in the socio-ecological model, sought to …

    umkc Repository record for Feasibility and Acceptability of a SystemCHANGE™ Intervention to Improve Medication Adherence in Older Adult Stroke Survivors: A Pilot Randomized Controlled Trial (opens in a new tab)

  8. Platelet Receptor Glycoprotein VI in Ischaemic Stroke

    … of GPVI-dimer could be a promising future antithrombotic target.

    cambridge Repository record for Platelet Receptor Glycoprotein VI in Ischaemic Stroke (opens in a new tab)

  9. Coaxially electrospun heparin-eluting scaffolds for vascular graft application

    … post-TBA-modification, did not fully retain its antithrombotic properties (54.9 % reduction), which was further reduced after incorporation and release (24.2 % reduction). HepNa+ , however, retained its full antithrombotic activity post coaxial incorporation and elution. Coaxial electrospinning …

    cape-town Repository record for Coaxially electrospun heparin-eluting scaffolds for vascular graft application (opens in a new tab)

  10. Enhancing the Use of Network Meta-analysis to Synthesize Information on Benefits and Harms of Drugs to Support Regulatory and Reimbursement Decisions in Canada

    … documents to populate a network meta-analysis of antithrombotic therapies for atrial fibrillation. In Chapter 3, the advantages and disadvantages of rapid network meta-analysis using ClinicalTrials.gov are investigated by re-doing Chapter 3 but only using data available in ClinicalTrials.gov and …

    ottawa-retro Repository record for Enhancing the Use of Network Meta-analysis to Synthesize Information on Benefits and Harms of Drugs to Support Regulatory and Reimbursement Decisions in Canada (opens in a new tab)

  11. Compositional Determinants of the Pharmacological Actions of Heparins

    … a higher anti-FXa/FIIa ratio, promotes a better antithrombotic and safety profile compared to non-enriched heparin derivatives. Overall, this dissertation provides a comprehensive biochemical and pharmacological investigation in which not only the molecular weight dependence, but also the …

    loyola-thes Repository record for Compositional Determinants of the Pharmacological Actions of Heparins (opens in a new tab)

  12. ACUTE ISCHEMIC STROKE: CANCER-RELATED STROKE AND MULTIMODAL ANALYSIS OF THROMBI.

    … collaborations, focusing on outcomes, antithrombotic and anticancer strategies, and the role of newly diagnosed vs known cancer. In parallel, we created the POLIclinico-Stroke-Thrombi-Analysis-Registry (POLISTAR) to prospectively collect thrombi with linked clinical, imaging, …

    milano Repository record for ACUTE ISCHEMIC STROKE: CANCER-RELATED STROKE AND MULTIMODAL ANALYSIS OF THROMBI. (opens in a new tab)

  13. The evaluation of novel nanoporous materials for use in interventional cardiology

    … of direct NO release from MOFs holds promise for antithrombotic interventions. This research provides valuable insights into the potential of NO-releasing MOF/polymer materials for use in medical devices. The material 5 wt% Zn CPO-27 MOF incorporated in the PEBAX 5533 polymer is identified as a …

    uhi-uk Repository record for The evaluation of novel nanoporous materials for use in interventional cardiology (opens in a new tab)

  14. A Microfluidic Approach For Investigating Thrombosis And Hemostasis: From Disease Models To Drug Testing

    … also displayed heightened sensitivity to antithrombotic drugs. The majority of the patients who underwent surgical operations had increased platelet deposition 24 hours after surgery whereas the trend for fibrin polymerization was less clear. The significant increase in platelet response …

    penn Repository record for A Microfluidic Approach For Investigating Thrombosis And Hemostasis: From Disease Models To Drug Testing (opens in a new tab)

  15. Exploring the therapeutic potential of the apelin receptor signalling axis, and angiotensin-converting enzyme 2 (ACE2) as the SARS-CoV-2 viral entry receptor, in the cardiovascular system

    … disorders, where the receptor also mediates antithrombotic responses. Here, four novel fluorescent ligands, designed as functional analogues of endogenous apelin and ELA peptides, were validated and used as a versatile tool for the qualitative and quantitative determination of pharmacological …

    cambridge Repository record for Exploring the therapeutic potential of the apelin receptor signalling axis, and angiotensin-converting enzyme 2 (ACE2) as the SARS-CoV-2 viral entry receptor, in the cardiovascular system (opens in a new tab)

  16. In vitro and in vivo studies on the activating platelet collagen receptor glycoprotein VI in mice

    … was performed to evaluate its potential as an antithrombotic target. The first mAb against (mouse) GPVI, JAQ1, was generated and used to demonstrate that GPVI requires the FcRgamma-chain for its expression and function and that this receptor is the central molecule in collagen-induced platelet …

    wurz-thes Repository record for In vitro and in vivo studies on the activating platelet collagen receptor glycoprotein VI in mice (opens in a new tab)

  17. Nanoparticle systems that exploit host biology for diagnosis and treatment of disease

    … increase in bleeding, the primary side-effect of antithrombotic therapy in the clinic. Finally, we investigated a two-component system whereby the first therapeutic entity induces the upregulation a molecular signal within a malignant environment to amplify the local recruitment of a secondary …

    mit Repository record for Nanoparticle systems that exploit host biology for diagnosis and treatment of disease (opens in a new tab)

  18. Mechanische Thromboseprophylaxe bei Hüft-Endoprothesen : prospektive Studie zum Einsatz des Venaflow-Gerätes

    … molecular weight heparin (LMWH; Fragmin), wore antithrombotic stockings and were mobilised the first day after operation. After theatre n=39 patients received the Venaflow for 3 days, further n=57 patients were followed up in the control- group. Every day during the doctor's round clinical signs …

    aachen Repository record for Mechanische Thromboseprophylaxe bei Hüft-Endoprothesen : prospektive Studie zum Einsatz des Venaflow-Gerätes (opens in a new tab)

  19. Targeting phosphatidylserine exposure in pro-coagulant platelets.

    … in pro-coagulant platelets could be a novel antithrombotic strategy.

    cambridge Repository record for Targeting phosphatidylserine exposure in pro-coagulant platelets. (opens in a new tab)

  20. Is the door closed? : In vitro studies on the pharmacokinetic effects of OATP1B1 gene-drug and drug-drug interactions.

    … was also investigated. Ticagrelor (an antithrombotic drug) and rosuvastatin (a cholesterol-lowering drug) are both commonly prescribed as secondary prevention after cardiovascular events. The in vitro inhibition assays using the same expression method and ticagrelor and rosuvastatin …

    helsinki Repository record for Is the door closed? : In vitro studies on the pharmacokinetic effects of OATP1B1 gene-drug and drug-drug interactions. (opens in a new tab)

Page 1 of 2